media

Markets

Market Nav

CASH FLOW

You can view the cash flow for the last 5 years.
Aurobindo Pharma Ltd.
( in Crs.)

ParticularsMar 23Mar 22Mar 21Mar 20Mar 19
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue1.001.001.001.001.00
      
Net Profit/Loss Before Extraordinary Items And Tax2612.503372.747343.593743.043091.35
      
Net CashFlow From Operating Activities2386.755016.483328.924381.281650.97
Net Cash Used In Investing Activities-3977.75-3211.56598.69-1567.64-2902.59
Net Cash Used From Financing Activities1814.41-2969.27-1364.81-1947.181919.06
Foreign Exchange Gains / Losses-0.060.20-2.124.78-1.80
Adjustments On Amalgamation / Merger / Demerger And Others6.41-3.2522.410.000.00
      
Net Inc/Dec In Cash And Cash Equivalents229.76-1167.402583.09871.24665.64
Cash And Cash Equivalents Begin of Year4162.515329.912746.821875.581209.94
Cash And Cash Equivalents End Of Year4392.274162.515329.912746.821875.58
ParticularsMar 23
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue1.00
  
Net Profit/Loss Before Extraordinary Items And Tax2612.50
Net CashFlow From Operating Activities2386.75
Net Cash Used In Investing Activities-3977.75
Net Cash Used From Financing Activities1814.41
Foreign Exchange Gains / Losses-0.06
Adjustments On Amalgamation / Merger / Demerger And Others6.41
Net Inc/Dec In Cash And Cash Equivalents229.76
Cash And Cash Equivalents Begin of Year4162.51
Cash And Cash Equivalents End Of Year4392.27